November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different ...
November 6, 2017 – Results from ORBITA, a prospective multi-center randomized blinded placebo-controlled study, found no ...
November 6, 2017 — One year follow-up data from the SCOUT I Early Feasibility Study for the Mitralign Trialign System ...
November 6, 2017 — The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months ...
November 6, 2017 — Three-year data from the FAME 2 study show patients with coronary artery disease who underwent a ...
November 6, 2017 — Elderly patients undergoing percutaneous coronary intervention (PCI) often receive bare-metal stents ...
November 3, 2017 — Biotronik's Orsiro drug-eluting stent (DES) demonstrated high long-term safety and clinical ...
November 3, 2017 — Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist RXi Mini ...
November 2, 2017 – Five-year results from the PREVAIL Trial comparing left atrial appendage closure (LAAC) with the ...
November 2, 2017 — The treatment of in-stent restenosis (ISR) remains challenging in clinical practice. The DARE (Drug ...
November 2, 2017 — Crossing the occlusion with a guidewire is often the most challenging part of chronic total occlusion ...
November 1, 2017 — OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
November 1, 2017 — The double kissing (DK) crush two-stent technique was associated with a lower rate of target lesion ...
November 1, 2017 — Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary ...
November 1, 2017 — Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter ...